✦ LIBER ✦

Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

✍ Scribed by Leder, Benjamin Z.; Tsai, Joy N.; Uihlein, Alexander V.; Burnett-Bowie, Sherri-Ann M.; Zhu, Yuli; Foley, Katelyn; Lee, Hang; Neer, Robert M.

Book ID: 121850166
Publisher: Endocrine Society
Year: 2014
Tongue: English
Weight: 611 KB
Volume: 99
Category: Article
ISSN: 0021-972X
DOI: 10.1210/jc.2013-4440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Teriparatide and denosumab, alone or com

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial

✍ Tsai, Joy N; Uihlein, Alexander V; Lee, Hang; Kumbhani, Ruchit; Siwila-Sackman, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 305 KB

Five years of denosumab exposure in wome

Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension

✍ Socrates Papapoulos; Roland Chapurlat; Cesar Libanati; Maria Luisa Brandi; Jacqu 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 256 KB 👁 1 views

The 3-year FREEDOM trial assessed the efficacy and safety of 60 mg denosumab every 6 months for the treatment of postmenopausal women with osteoporosis. Participants who completed the FREEDOM trial were eligible to enter an extension to continue the evaluation of denosumab efficacy and safety for up

A Four-Year Randomized Controlled Trial

A Four-Year Randomized Controlled Trial of Hormone Replacement and Bisphosphonate, Alone or in Combination, in Women with Postmenopausal Osteoporosis

✍ Sunil J Wimalawansa MD; PhD 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Safety and tolerability of bazedoxifene

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

✍ T. J. de Villiers; A. A. Chines; S. Palacios; P. Lips; A. Z. Sawicki; A. B. Levi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 269 KB

Safety and tolerability of bazedoxifene

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: Results of A 5-year, randomized, placebo-controlled phase 3 trial

✍ T.J. de Villiers; D.L. Kendler; A.A. Chines; P. Lips; J.M. Kaufman; A.B. Levine; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Safety and Tolerability of Bazedoxifene

Safety and Tolerability of Bazedoxifene in Postmenopausal Women With Osteoporosis: Results of a 5-year, Randomized, Placebo-controlled Phase 3 Trial

✍ T. de Villiers; D. Kendler; A. Chines; P. Lips; J. Kaufman; A. Levine; N. Mairon 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 177 KB